NEW YORK (GenomeWeb News) – Abbott today reported worldwide molecular diagnostics sales of $73 million, up around 21 percent, not including the effects of currency translation, over its 2008 MDx sales.

The Abbott Park, Ill.-based pharmaceuticals and medical products giant said that including the negative effects of foreign exchange its global molecular diagnostic sales were up 11 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.